These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7738422)

  • 41. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH; Triplett DA
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A new cause of familial thrombophilia: resistance to the effect of activated protein C].
    Emmerich J; Alhenc-Gelas M; Gandrille S; Fiessinger JN; Aiach M
    Presse Med; 1994 Sep; 23(28):1285-7. PubMed ID: 7984524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary antiphospholipid syndrome is not associated with activated protein C resistance caused by factor V Arg 506 -->Gln mutation.
    Biousse V; Piette JC; Frances C; Bletry O; Papo T; Tournier-Lasserve E; Duchemin J; Aiach M
    J Rheumatol; 1995 Jun; 22(6):1215. PubMed ID: 7674266
    [No Abstract]   [Full Text] [Related]  

  • 44. Thrombophilia, homocystinuria, and mutation of the factor V gene.
    D'Angelo A; Fermo I; D'Angelo SV
    N Engl J Med; 1996 Jul; 335(4):289; author reply 290. PubMed ID: 8657258
    [No Abstract]   [Full Text] [Related]  

  • 45. Activated protein C resistance and factor V Leiden mutation are risk factors for cerebral sinus thrombosis.
    Siegert CE; Smelt AH; de Bruin TW
    Stroke; 1997 Jun; 28(6):1291-2. PubMed ID: 9183366
    [No Abstract]   [Full Text] [Related]  

  • 46. Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease.
    März W; Seydewitz H; Winkelmann B; Chen M; Nauck M; Witt I
    Lancet; 1995 Feb; 345(8948):526. PubMed ID: 7861906
    [No Abstract]   [Full Text] [Related]  

  • 47. Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation.
    Brey RL; Coull BM
    Stroke; 1996 Oct; 27(10):1719-20. PubMed ID: 8841316
    [No Abstract]   [Full Text] [Related]  

  • 48. [Protein C defects as the basis of a thrombophilic state].
    Vogel G; Lauten G; Machulik M; Fischer C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):901-5. PubMed ID: 2483709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor VLeiden and thrombophilia.
    Kalafatis M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):620-7. PubMed ID: 9108773
    [No Abstract]   [Full Text] [Related]  

  • 50. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM.
    Gandrille S; Greengard JS; Alhenc-Gelas M; Juhan-Vague I; Abgrall JF; Jude B; Griffin JH; Aiach M
    Blood; 1995 Jul; 86(1):219-24. PubMed ID: 7795227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrovascular disease risk factors: neuroradiologic findings in patients with activated protein C resistance.
    Provenzale JM; Barboriak DP; Davey IC; Ortel TL
    Radiology; 1998 Apr; 207(1):85-9. PubMed ID: 9530303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease.
    Lesprit P; Wechsler B; Piette JC; Du-Boutin LT; Godeau P; Alhenc-Gelas M; Aiach M
    Ann Rheum Dis; 1995 Oct; 54(10):860. PubMed ID: 7492231
    [No Abstract]   [Full Text] [Related]  

  • 53. Coagulation factor V Leiden mutation may have a racial background.
    Fujimura H; Kambayash J; Monden M; Kato H; Miyata T
    Thromb Haemost; 1995 Nov; 74(5):1381-2. PubMed ID: 8607128
    [No Abstract]   [Full Text] [Related]  

  • 54. [The role of protein C in coagulation and fibrinolysis].
    Fijałkowska I; Babińska A; Cierniewski CS
    Postepy Biochem; 1992; 38(4):178-83. PubMed ID: 1293597
    [No Abstract]   [Full Text] [Related]  

  • 55. Activated protein C resistance and inherited thrombosis.
    Rodgers GM
    Am J Clin Pathol; 1995 Mar; 103(3):261-2. PubMed ID: 7872247
    [No Abstract]   [Full Text] [Related]  

  • 56. Activated protein C resistance in childhood stroke.
    Ganesan V; Kelsey H; Cookson J; Osborn A; Kirkham FJ
    Lancet; 1996 Jan; 347(8996):260. PubMed ID: 8551897
    [No Abstract]   [Full Text] [Related]  

  • 57. [Activated protein C resistance in the Japanese].
    Ozawa T
    Rinsho Ketsueki; 1996 Sep; 37(9):790-3. PubMed ID: 8914464
    [No Abstract]   [Full Text] [Related]  

  • 58. [Role of protein C in regulating blood coagulation and fibrinolysis].
    Zawilska K; Psuja P; Sowier J
    Przegl Lek; 1987; 44(4):410-3. PubMed ID: 3628850
    [No Abstract]   [Full Text] [Related]  

  • 59. Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight.
    Clark P; Walker ID; Greer I
    Lancet; 1999 Jan; 353(9149):292-3. PubMed ID: 9929027
    [No Abstract]   [Full Text] [Related]  

  • 60. [Protein C].
    Riabov GA; Pasechnik IN; Azizov IuM
    Ter Arkh; 1989; 61(7):151-3. PubMed ID: 2686064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.